理气活血方联合孕三烯酮在卵巢型子宫内膜异位症腹腔镜保守性手术后的应用效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the clinical effect of Liqi Huoxue Decoction combined with Gestrinone on the treatment of ovarian endometriosis(OEMs)after laparoscopic conservative surgery.Methods A total of 68 patients with OEMs undergoing laparoscopic conservative surgery who treated in Guangzhou Hospital of Integrated Traditional and Western Medicine from June 2017 to June 2019 were selected as the research objects.According to random number table method,they were divided into control group and observation group,34 cases in each group.The control group was orally taken Gestrinone Capsule after surgery,and the observation group was additively taken Liqi Huoxue Decoction on the basis of the control group.The two groups were treated for 3 months.The duration of dysmenorrhea,visual analog scale(VAS)score,serum estradiol(E2),follicle stimulating hormone(FSH),cancer antigen 125(CA125)and positive rate of anti-endometrial antibody(EMAb)were compared between two groups before and after treatment.Results After treatment,the duration of dysmenorrhea in both groups was shorter than before treatment,VAS score,levels of E2,FSH,CA125 and positive rate of EMAb were lower than before treatment,the differences were statistically significant(P＜0.05).The duration of dysmenorrhea after treatment in the observation group was shorter than that in the control group,the VAS score,E2,FSH,CA125 levels and the positive rate of EMAb were all lower in the observation group than those in the control group,the differences were statistically significant(P＜0.05).Conclusion Liqi Huoxue Decoction combined with Gestrinone in the treatment of patients with OEMs after laparoscopic conservative surgery can significantly shorten the dysmenorrhea time,reduce the VAS score,reduce the serum E2,FSH,CA125 levels and EMAb positive rate,and has a good curative effect.

Key words： Ovarian endometriosis Liqi Huoxue Decoction Gestrinone Sex hormone Cancer antigen 125 Anti endometrial antibody

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHENG Ying-hui
	CHEN Xuan-qiong

Cite this article:

ZHENG Ying-hui,CHEN Xuan-qiong. Application effect of Liqi Huoxue Decoction combined with Gestrienone in the treatment of ovarian endometriosis after laparoscopic conservative surgery[J]. 中国当代医药, 2021, 28(14): 177-180.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I14/177

[1]	谢幸，孔北华，段涛.妇产科学[M].9版.北京：人民卫生出版社，2018：261-267.
[2]	钟沛文，张四友，关宝星.腹腔镜手术联合曲普瑞林治疗轻度子宫内膜异位症并不孕临床观察[J].中国药业，2019，28（22）：41-43.
[3]	中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症长期管理中国专家共识[J].中华妇产科杂志，2018，53（12）：836-841.
[4]	刘多，沈慧敏，梁炎春，等.节段性肠切除术治疗肠道子宫内膜异位症患者的临床疗效及生命质量分析[J].中华妇产科杂志，2016，51（7）：503-508.
[5]	Revised American Fertility Society classification of endometriosis：1985[J].Fertil Steril，1985，43（3）：351-352．
[6]	张玉珍.中医妇科学[M].新世纪第2版.北京：中国中医药出版社，2007：140.
[7]	高万露，汪小海.视觉模拟疼痛评分研究的进展[J].医学研究杂志，2013，42（12）：144-146.
[8]	中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南[J].中华妇产科杂志，2015，50（3）：161-169.
[9]	吕艳红，吴涵，贺媛媛，等.卵巢型子宫内膜异位症患者保守性手术治疗效果[J].中国医科大学学报，2021，50（1）：14-18.
[10]	张莉，金晶，季菲.丹莪妇康煎膏联合孕三烯酮治疗子宫内膜异位症疗效及对患者CA125、TNF-a和IL-6水平的影响[J].陕西中医，2020，41（10）：1370-1372.
[11]	Foster W.Diagnosing endometriosis：CA125 rules in，but not out[J].BJOG，2016，123（11）：1769．
[12]	吕亚丽，陈勇，徐敏.联合检测血清IL-33与CA-125在诊断子宫内膜异位症的价值分析[J].四川医学，2020，41（11）：1139-1142.
[13]	杨婧如，熊兴林，顾艮莹.血清CA125、HE4、VEGF检测诊断子宫内膜异位症价值[J].中国计划生育学杂志，2020，28（12）：2067-2070.
[14]	王艳玲，黄建军.腹腔镜手术联合孕三烯酮治疗子宫内膜异位症的效果及对血清CA125水平的影响[J].临床合理用药，2020，13（8）：84-86.
[15]	刘维.腹腔镜联合促性腺激素释放激素激动剂治疗子宫内膜异位症的临床效果[J].中国当代医药，2019，26（20）：61-63.
[16]	胡海雷，周兴辉，林君平，等.血清抗子宫内膜抗体水平与子宫内膜异位症病情的相关性分析[J].中国妇幼保健，2020，35（21）：3956-3958.
[17]	车玲玲，张延荃，马瑜宏，等.参皂九味汤治疗子宫内膜异位症的疗效及对HE4、EMAb和CA125水平的影响[J].现代中西医结合杂志，2018，27（5）：502-505.
[18]	聂莹，黄会.散结镇痛胶囊联合米非司酮片治疗子宫内膜异位症的临床疗效及对患者血清抗子宫内膜抗体的影响[J].中国医药科学，2019，9（6）：114-116.